it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done. .
despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6. .
OFF DEAL
OFF DEAL
181 Used Today